You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MGD

Showing 26 - 50 of 169
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Meibomian Gland Expression on Corneal Aberrations in MGD

Completed
  • Meibomian Gland Dysfunction
    • Wenzhou, Zhejiang, China
      Eye Hospital of Wenzhou Medical College
    Aug 31, 2021

    Meibomian Gland Dysfunction, Evaporative Dry Eye Disease Trial in United States (Systane iLux® Dry Eye System, LipiFlow® Thermal

    Completed
    Has Results
    • Meibomian Gland Dysfunction
    • Evaporative Dry Eye Disease
    • Systane iLux® Dry Eye System
    • LipiFlow® Thermal Pulsation System
    • Long Beach, California
    • +14 more
    Sep 13, 2021

    Hormone Replacement Therapy in Treating Perimenopausal MGD

    Recruiting
    • Meibomian Gland Dysfunction
    • Hormone replacement therapy
    • Hangzhou, Zhejiang, China
    • +1 more
    Sep 9, 2021

    Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

    Terminated
    • Mesothelioma
    • +12 more
    • MGD009
    • Los Angeles, California
    • +19 more
    Feb 4, 2022

    Meibomian Gland Dysfunction, Dry Eye Trial in Seattle (Systane iLux thermal pulsation treatment)

    Recruiting
    • Meibomian Gland Dysfunction
    • Dry Eye
    • Systane iLux thermal pulsation treatment
    • Seattle, Washington
      Periman Eye Institute
    Mar 23, 2022

    Evaporative Dry Eye Trial in Encinitas, San Diego (iLux 2020 System)

    Completed
    Has Results
    • Evaporative Dry Eye
    • iLux 2020 System
    • Encinitas, California
    • +2 more
    Oct 20, 2020

    Dry Eye, Meibomian Gland Dysfunction Trial in Valencia (Hydrocortisone Ophthalmic, MGD Rx EyeBag® eyelid warming device,

    Recruiting
    • Dry Eye
    • Meibomian Gland Dysfunction
    • Hydrocortisone Ophthalmic
    • +3 more
    • Valencia, Spain
      Hospital La Fe
    Dec 2, 2021

    AML Trial in Worldwide (Flotetuzumab dose escalation, Flotetuzumab dose expansion, Ruxolitinib)

    Active, not recruiting
    • AML
    • Flotetuzumab dose escalation
    • +2 more
    • Duarte, California
    • +42 more
    Mar 7, 2022

    Meibomian Gland Dysfunction, Dry Eye Trial in Australia, Canada, New Zealand (AZR-MD-001 Low Dose, AZR-MD-001 Mid Dose,

    Completed
    • Meibomian Gland Dysfunction
    • Dry Eye
    • AZR-MD-001 Low Dose
    • +3 more
    • Chatswood, New South Wales, Australia
    • +29 more
    Nov 23, 2022

    Cataracts, Meibomian Gland Dysfunction (MGD) Trial in United States (LipiFlow Thermal Pulsation System)

    Completed
    Has Results
    • Cataracts
    • Meibomian Gland Dysfunction (MGD)
    • LipiFlow Thermal Pulsation System
    • Bakersfield, California
    • +4 more
    Apr 1, 2021

    Non-Hodgkin's Lymphoma Trial in United States (Y-90-Zevalin, Moxtezafin Gadolinium, Rituximab)

    Terminated
    Has Results
    • Non-Hodgkin's Lymphoma
    • Berkeley, California
    • +8 more
    Sep 6, 2021

    Meibomian Gland Dysfunction, Dry Eye Syndromes, Ocular Surface Disease Trial in San Antonio (Zocular Eyelid System Treatment)

    Completed
    • Meibomian Gland Dysfunction
    • +2 more
    • Zocular Eyelid System Treatment
    • San Antonio, Texas
      Rosenberg School of Optometry
    Jul 13, 2022

    Dry Eye Syndromes Trial in Kansas City (Lifitegrast Ophthalmic, Systane Free, Lipiflow)

    Active, not recruiting
    • Dry Eye Syndromes
    • Lifitegrast Ophthalmic
    • +2 more
    • Kansas City, Missouri
      joseph Tauber
    Oct 25, 2022

    Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,

    Active, not recruiting
    • Gastric Cancer
    • +2 more
    • margetuximab
    • +4 more
    • Scottsdale, Arizona
    • +72 more
    Aug 24, 2022

    Meibomian Gland Dysfunction, Demodex Infestation of Eyelid, Blepharitis Trial in Northridge, Shelby (Vehicle of TP-03)

    Recruiting
    • Meibomian Gland Dysfunction
    • +3 more
    • Vehicle of TP-03
    • Northridge, California
    • +1 more
    Sep 28, 2023

    Meibomian Gland Dysfunction Trial in Guangzhou (Thermal pulsation, Intense pulsed light therapy, Manual meibomian gland

    Recruiting
    • Meibomian Gland Dysfunction
    • Thermal pulsation
    • +2 more
    • Guangzhou, Guangdong, China
    • +1 more
    Mar 29, 2022

    Meibomian Gland Dysfunction Trial in Aurora (Tear Restore Mask)

    Enrolling by invitation
    • Meibomian Gland Dysfunction
    • Tear Restore Mask
    • Aurora, Colorado
      University of Colorado, Dept. of Ophthalmology
    Feb 16, 2022

    Dry Eye Disease Trial in Murcia (Microblepharoexfoliation, Intense pulse light, Meibomian gland expression)

    Completed
    • Dry Eye Disease
    • Microblepharoexfoliation
    • +3 more
    • Murcia, Spain
      Novovision ophthalmologic clinic
    May 9, 2023

    Dry Eye Syndromes, Meibomian Gland Dysfunction Trial in Vienna (Azithromycin, Doxycycline)

    Recruiting
    • Dry Eye Syndromes
    • Meibomian Gland Dysfunction
    • Vienna, Austria
      Gerhard Garhofer
    Apr 6, 2022

    Dry Eye, Meibomian Gland Dysfunction Trial in Jerusalem (Intense Pulsed Light (IPL) therapy, Sham therapy)

    Completed
    • Dry Eye
    • Meibomian Gland Dysfunction
    • Intense Pulsed Light (IPL) therapy
    • Sham therapy
    • Jerusalem, Israel
      Shaare Zedek
    Feb 19, 2020

    Evaporative Dry Eye Trial in Tanta (IPL therapy, Punctal plugs)

    Completed
    • Evaporative Dry Eye
    • IPL therapy
    • Punctal plugs
    • Tanta, Egypt
      Faculty of Medicine, Tanta University
    Apr 15, 2022

    Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Enoblituzumab, Retifanlimab,

    Recruiting
    • Head and Neck Cancer
    • +2 more
    • Enoblituzumab
    • +2 more
    • Baltimore, Maryland
    • +41 more
    May 16, 2022

    Dry Eye Disease Trial (IPRL device, pharmacological therapy & Eyelid hygiene)

    Not yet recruiting
    • Dry Eye Disease
    • IPRL device
    • pharmacological therapy & Eyelid hygiene
    • (no location specified)
    Oct 30, 2022

    Meibomian Gland Dysfunction, MGD-Meibomian Gland Dysfunction Trial in United States (0.3% Topical Minocycline Ointment, 1%

    Completed
    • Meibomian Gland Dysfunction
    • MGD-Meibomian Gland Dysfunction
    • 0.3% Topical Minocycline Ointment
    • +2 more
    • Azusa, California
    • +19 more
    Mar 1, 2021

    Dry Eye Trial in Gallarate (Rexon-Eye)

    Completed
    • Dry Eye
    • Rexon-Eye
    • Gallarate, VA, Italy
      Centro Oculistico Borroni
    Nov 3, 2023